Risk imparted by various parameters of smoking in Japanese men with type 2 diabetes on their development of microalbuminuria: Analysis from the Tsukuba Kawai Diabetes Registry

Diabetes Care

Volumn 30, Issue 5, 2007, Pages 1286-1288

  Saito, Kazumi ^a,b,c   Sone, Hirohito ^a,b   Kawai, Koichi ^c   Tanaka, Shiro ^d   Kodama, Satoru ^a,b   Shu, Miao ^a,b   Suzuki, Emiko ^a   Kondo, Kazuo ^a   Yamamoto, Shigeru ^a   Shimano, Hitoshi ^b   Ohashi, Yasuo ^d   Yamada, Nobuhiro ^b  

^a OCHANOMIZU UNIVERSITY   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c Kawai Clinic   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIHYPERTENSIVE AGENT; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; HUMAN; JAPANESE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN URINE LEVEL; RISK FACTOR; SMOKING;

ADULT; ALBUMINURIA; ANALYSIS OF VARIANCE; DATABASES, FACTUAL; DIABETES MELLITUS, TYPE 2; HUMANS; JAPAN; MIDDLE AGED; REGISTRIES; RISK ASSESSMENT; SMOKING;

EID: 34247555428     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-2149     Document Type: Article

References (18)

1. Chase HP, Garg SK, Marshall G, Berg CL, Harris S, Jackson WE, Hamman RE: Cigarette smoking increases the risk of albuminuria among subjects with type 1 diabetes. JAMA 265:614-617, 1991
2. Scott LJ, Warram JH, Hanna LS, Laffel LMB, Ryan L, Krolewski AS: A nonlinear effect of hyperglycemia and cigarette smoking are major determinants of the onset of microalbuminuria in type 1 diabetes. Diabetes 50:2842-2849, 2001
3. Hovind P, Tarnow L, Rossing P, Jensen BR, Graae M, Torp I, Binder C, Parving HH: Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study. BMJ 328:1105-1109, 2004
4. Ravid M, Brosh D, Ravid-Safran D, Levy Z, Rachmani R: Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia. Arch Intern Med 158:998-1004, 1998
5. Chaturvedi N, Bandinelli S, Mangili R, Penno G, Rottiers RE, Fuller JH, on behalf of the EURODIAB Prospective Complications Study Group: Microalbuminuria in type 1 diabetes: rates, risk factors and glysemic threshold. Kidney Int 60:219-227, 2001
6. Rossing P, Hougaard P, Parving HH: Risk factors for development if incipient and overt diabetic nephropathy in type 1 diabetic patients: a 10-year prospective observational study. Diabetes Care 25:859-864, 2002
7. Svensson M, Sundkvist G, Arnqvist HJ, Björk E, Blohmé G, Bolinder J, Henricsson M, Nyström L, Torffvit O, Waernbaum IW, Östman J, Eriksson JW: Signs of nephropathy may occur early in young adults with despite modern diabetes management: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS). Diabetes Care 26:2903-2909, 2003
8. Cederholm J, Eliasson B, Nilsson PM, Weiss L, Gudbjörnsdottir S, for the Steering Committee of the Swedish National Diabetes Register: Microalbuminuria and risk factors in type 1 and type 2 diabetic patients. Diabetes Res Clin Pract 67:258-266, 2005
9. Microalbuminuria Collaborative Study Group: Risk factors for development of microalbuminuria in insulin dependent diabetic patients: a cohort study. BMJ 306:1235-1239, 1993
10. Gall MA, Hougaard P, Borch-Johnsen K, Parving HH: Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study. BMJ 314:783-788, 1997
11. Forsblom CM, Groop PH, Ekstrand A, Tötterman KJ, Sane T, Saloranta C, Groop L: Predictors of progression from normoalbuminuria to microalbuminuria in NIDDM. Diabetes Care 21:1932-1938, 1998
12. Retnakaran R, Cull CA, Thorne KI, Adler AI, Holman RR: Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74. Diabetes 55:1832-1839, 2006
13. Saito K, Yamada N, Sone H: Cigarette smoking is associated with low glomerular filtration rate in male patients with type 2 diabetes: response to De Cosmo et al (Online Letter). Diabetes Care 30:e2, 2007
14. Kristeller JL: Managing smoking as a risk factor in cardiac disease: an educational, behavioral, and pharmacologic perspective. In Lifestyle Medicine. Rippe JM, Ed. Malden, MA, Blackwell Science, 1999, p. 67-80
15. World Health Organization: Diabetes Mellitus: Report of a WHO Study Group. Geneva. World Health Org., 1985 (Tech. Rep. Ser., no. 727)
16. Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41, 1976
17. Sawicki PT, Didjurgeit U, Mühlhauser I, Bender R, Heinemann L, Berger M: Smoking is associated with progression of diabetic nephropathy. Diabetes Care 17:126-131, 1994
18. Orth SR, Schroeder T, Ritz E, Ferrari P: Effects of smoking on renal function in patients with type 1 and type 2 diabetes mellitus. Nephrol Dial Transplant 20:2414-2419, 2005